Effect of eculizumab treatment in patients with paroxysmal nocturnal hemoglobinuria with or without high disease activity: Real-world findings from the International Paroxysmal Nocturnal Hemoglobinuria Registry

Hochsmann, B; de Fontbrune, FS; Lee, JW; Kulagin, AD; Hillmen, P; Wilson, A; Marantz, JL; Schrezenmeier, H

Hochsmann, B (通讯作者),Univ Hosp Ulm, Inst Clin Transfus Med & Immunogenet, Helmholtzstr 10, D-89081 Ulm, Germany.

EUROPEAN JOURNAL OF HAEMATOLOGY, 2022; 109 (3): 197

Abstract

Background The effects of eculizumab treatment in paroxysmal nocturnal hemoglobinuria (PNH) patients with or without high-disease activity (HDA), defi......

Full Text Link